32,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Understanding of oxorhenium(V) Rhenium(V) complexes as radiopharmaceuticals for therapy and diagnosis have received attention, because of their suitable radionuclear properties, i.e., 186Re: Emax = 1.1 MeV for beta-emission and Emax = 0.137 MeV for gamma-emission with t1/2 = 90.6 h, 188Re: Emax = 2.1 MeV for beta-emission and Emax = 0.155 MeV for gamma-emission with t1/2 = 17 h. Hence, chemical properties of various monooxo- and dioxorhenium(V) (ReO3+ and ReO2+) complexes have been examined as basic studies for their application to radiopharmaceutical. However, only limited information is…mehr

Produktbeschreibung
Understanding of oxorhenium(V) Rhenium(V) complexes as radiopharmaceuticals for therapy and diagnosis have received attention, because of their suitable radionuclear properties, i.e., 186Re: Emax = 1.1 MeV for beta-emission and Emax = 0.137 MeV for gamma-emission with t1/2 = 90.6 h, 188Re: Emax = 2.1 MeV for beta-emission and Emax = 0.155 MeV for gamma-emission with t1/2 = 17 h. Hence, chemical properties of various monooxo- and dioxorhenium(V) (ReO3+ and ReO2+) complexes have been examined as basic studies for their application to radiopharmaceutical. However, only limited information is available concerning the electrochemical properties and stereoisomerism of oxorhenium(V) complexes in non-aqueous solutions, in spite of importance in the relation to in vivo behavior, i.e., the reactivity towards redox agents. This book is covering a doctoral study and its results on the related subjects.
Autorenporträt
Ali Canlier obtuvo su doctorado en ingeniería nuclear en el Instituto de Tecnología de Tokio, Tokio. Actualmente es Research Fellow en la Escuela de Graduados de EEWS en KAIST, donde está llevando a cabo una investigación sobre química del Boro y meso- / nanomateriales. Puede hablar turco, inglés y japonés con fluidez, coreano y alemán como principiante.